AstraZeneca gets FDA approval for Farxiga to treat chronic kidney disease
Farxiga is said to have reduced the risk of the composite of worsening of renal function, end-stage kidney…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 May 21
Farxiga is said to have reduced the risk of the composite of worsening of renal function, end-stage kidney…
03 May 21
The company filed its sBLA application based on the Phase 3 CheckMate -274 trial, in which Opdivo increased…
30 Apr 21
Ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged two years and…
29 Apr 21
The acquisition follows Pfizer’s initial equity investment in Amplyx, as part of the antifungal therapies developer's Series C…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
28 Apr 21
Exscientia intends to use the funding to advance its pipeline through clinical testing along with expanding its technology…
28 Apr 21
The company is also committed to donating more than $5m in supplies and equipment to support the pandemic…
27 Apr 21
Sanofi to dedicate its site in Ridgefield, New Jersey to perform fill and finish operations for up to…
26 Apr 21
GSK claimed that its Jemperli is the first anti-PD-1 therapy approved for recurrent or advanced endometrial cancer
26 Apr 21
Use of J&J’s single-shot Covid-19 vaccine was paused after the vaccination induced a rare and severe thrombosis with…
23 Apr 21
The new facility will feature advanced technologies, the latest manufacturing equipment and advanced digital systems to deliver critical…